Credit Suisse Ag 10x Genomics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 1,456,428 shares of TXG stock, worth $20.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,456,428

Previous 1,250,102 16.5%

Holding current value

$20.8 Million

Previous $70 Million 21.87%

% of portfolio

0.05%

Previous 0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$36.08 - $54.3 $7.44 Million - $11.2 Million	206,326 Added 16.5%	1,456,428 $54.7 Million
Q4 2023 Feb 08, 2024	SELL	$34.32 - $57.55 $3 Million - $5.03 Million	-87,334 Reduced 6.53%	1,250,102 $70 Million
Q3 2023 Nov 13, 2023	SELL	$40.86 - $62.98 $3.4 Million - $5.24 Million	-83,187 Reduced 5.86%	1,337,436 $55.2 Million
Q2 2023 Aug 11, 2023	SELL	$50.96 - $58.72 $26,091 - $30,064	-512 Reduced 0.04%	1,420,623 $79.3 Million
Q1 2023 May 10, 2023	SELL	$35.33 - $55.79 $25.2 Million - $39.8 Million	-714,199 Reduced 33.45%	1,421,135 $79.3 Million
Q4 2022 Feb 13, 2023	SELL	$24.4 - $41.3 $478,972 - $810,719	-19,630 Reduced 0.91%	2,135,334 $77.8 Million
Q3 2022 Nov 10, 2022	BUY	$28.48 - $52.59 $13.3 Million - $24.6 Million	468,207 Added 27.76%	2,154,964 $61.4 Million
Q2 2022 Aug 12, 2022	BUY	$36.95 - $82.41 $11.5 Million - $25.6 Million	311,027 Added 22.61%	1,686,757 $76.3 Million
Q1 2022 May 16, 2022	BUY	$55.7 - $145.79 $16 Million - $41.9 Million	287,307 Added 26.4%	1,375,730 $105 Million
Q4 2021 Feb 14, 2022	SELL	$135.05 - $182.59 $10.4 Million - $14 Million	-76,926 Reduced 6.6%	1,088,423 $162 Million
Q3 2021 Nov 12, 2021	SELL	$145.58 - $192.14 $21 Million - $27.7 Million	-144,130 Reduced 11.01%	1,165,349 $170 Million
Q2 2021 Aug 16, 2021	SELL	$134.22 - $202.37 $2.94 Million - $4.44 Million	-21,934 Reduced 1.65%	1,309,479 $256 Million
Q1 2021 May 14, 2021	BUY	$140.25 - $196.86 $59.2 Million - $83.1 Million	421,901 Added 46.39%	1,331,413 $241 Million
Q4 2020 Feb 12, 2021	BUY	$126.47 - $163.7 $31.6 Million - $40.9 Million	249,912 Added 37.89%	909,512 $129 Million
Q3 2020 Nov 13, 2020	SELL	$87.44 - $125.0 $2.9 Million - $4.15 Million	-33,196 Reduced 4.79%	659,600 $82.2 Million
Q2 2020 Aug 12, 2020	BUY	$58.39 - $89.31 $4.49 Million - $6.87 Million	76,941 Added 12.49%	692,796 $61.9 Million
Q1 2020 May 13, 2020	BUY	$51.57 - $106.62 $21.4 Million - $44.2 Million	414,769 Added 206.26%	615,855 $38.4 Million
Q4 2019 Feb 12, 2020	BUY	$46.07 - $79.54 $9.26 Million - $16 Million	201,086 New	201,086 $15.3 Million

Others Institutions Holding TXG

# of Institutions

290

Shares Held

94.7M

Call Options Held

263K

Put Options Held

85.1K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.36B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account